
A Natural Synergist in Colon Cancer Treatment
Providing Relief for Sufferers
Colon cancer is disease that can be found in the region extending from the large intestine to the rectum.
1 in 12 Australians will be diagnosed with this disease by the time they are 85 and if caught early enough 90% of people can be treated successfully. Causes and risk factors include:
- older age
- a diet high in red or processed meats
- family history
- history of inflammatory bowel disease
Symptoms can be vague and many times a patient may not have symptoms at all. One of the earliest signs may be bleeding. Some common signs and symptoms include changes in bowel habits, diarrhoea or constipation, a sense that the bowel is not empty, blood in the stool, stools that are narrower than usual, general abdominal discomfort, weight loss, fatigue and vomiting.
Some studies have suggested a connection between glucose and cancer. Holding blood sugar levels within the critical limits has been known to assist with those already suffering from the disease. Some evidence has suggested that sugars like glucose feed cancer cells more efficiently than starches, which is why it is important to monitor glucose levels.
Avemar - an Excellent Addition
Apart from assisting with a healthier lifestyle and a more nutritious diet, Avemar is an excellent addition as a dietary supplement for patients who have undergone Colon Cancer Treatment such as surgery, chemotherapy and radiation therapy. With extremely promising results, this product, in conjunction with conventional medical treatment can decrease the side effects of both chemotherapy and radiotherapy- improving the quality of life for sufferers.
Avemar has been shown to have a synergistic effect with various conventional Colon Cancer Treatments. The supportive application of Avemar is highly recommended when patients undergo surgery, radiotherapy or chemotherapy as it can significantly inhibit overall tumour progression, the formation of new cancers and prolong the survival of those suffering.
This fermented wheat germ extract in combination with surgery plus radio/chemotherapy may inhibit overall tumour progression including the formation of new disease and may actually prolong survival for patients. A study demonstrated a reduction from 23.1% to 7.6%, over six months with patients that received Avemar and those who did not.
Additional research indicates that continuous supplementation of Avemar in excess of 6 months is beneficial to patients with this disease; irrespective of age.
Avemar has been extensively studied for its ability to boost the quality of life in patients who have had Colon Cancer Treatment; due to its ability to enhance the immune system.
As a wheat germ extract, Avemar is the only nutriment in its category: specifically approved for use as a complementary treatment. To find out more or to purchase Avemar contact us.
View CNN World Report
CNN WORLD REPORT 2006
